Company Overview and News
Consumer stocks are on fire so far in 2018 — the Consumer Discretionary Select SPDR ETF (NYSEARCA:XLY) is up 14% year to date through August 13, double the performance of the S&P 500 — and that’s got Goldman Sachs (NYSE:GS) singing the praises of 7 companies that include a hotel chain, food services business, a casino operator, and several more.
H BXG BBX DRI MDLZ SKX BETR GS BJRI SBUX ARMK HSY DPZ PZZA
In the U.S. retail landscape, the strength seen in consumer spending continued into the second quarter of 2018. In fact, analysts polled by Thomson Reuters are becoming more bullish on consumer spending, as retailers get ready to report their earnings for Q2 2018.
DFRG FRAN TXRH TIF NFLX PIR AMZN LULU WING MCD RRGB YUMC FRSH GME VSTO BKNG BJRI DAVE TRI SBUX LOCO PLAY URBN DPZ
LONDON, Aug 13 (Reuters) - British shares dipped on Monday as the Turkish currency crisis continued to rattle global markets while a possible 1.17 billion pound bid for esure sent shares in the insurance company surging over 30 percent.
DPUKY OML CHG BC88 DPZ
LONDON, Aug 13 (Reuters) - British shares dipped on Monday as the Turkish currency crisis continued to shake global markets with stock indexes declining from Asia to Europe.
DPUKY CHG BC88 DPZ
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning.
SYY AMAL RUTH BECN QES WHR HABT VIAB STI-A TSN WING SNAP MRCY WHD JCOM NWSA GPRE CRSP MDT REV GPK ZOES VCTR MGM WSO DFRG CTB OLED RAD GMVHF TEN HMI FLBD AGN CL AAPL UCBI KO USAP CBS GJV RRGB MUSA MCHP DDD "QES" VC TSLA CAKE APTV VPG BYD ARHVF EAT XON AMRS BLMN LDOS CVS UAL AMZN AIT NDSN CABO UPS KDP AAL CARS BR STE MAR REVG STI CLX BKEP TXRH DAN PG YELP TREC CDLX STMP ANDV MAR.WI MYL TSNU NWS KWR GM DIN FRPT DIS ECL F M FDX K BMI TGT ZG BKNG EOLS THRM DPZ ORLY
It’s a different market than it was at the beginning of 2018. Volatility has returned, even if it remains modest relative to historical levels. Big names like Procter & Gamble (NYSE:PG) and Walmart (NYSE:WMT), among others, have seen precipitous share price declines after record highs. What’s more, we’ve seen the first trillion-dollar company in Apple (NASDAQ:AAPL)
NTRI YUM XOM WMT AMZN AEO CMCSK UPS MPX WTW MCFT PFIZER BP NATH BRBW CGBBW ROKU NVS MBUU PFE BC VMI PG CCV CCZ LB BAC CHTR AAPL PFZ C CMCSA FDX T JPM CCV.CL CVX TSLA 500680 DPZ
There’s a fundamental mathematical proposition that makes shorting stocks risky. A short sale — a sale of borrowed stock, made with the intention of buying it back at a cheaper price later — in theory has unlimited losses. A long investor can only lose 100% of her money at most. But a short could lose multiples of the capital originally at risk.
MDGL FB POSTZ SPWR POSTU SKT NFLX AXDX] HRI SIRI MTCH AMZN SPOT AABA AAPL WATT DIS BGS OSTK RDEN SYNA AMC IAC P AXDX ICPT DLGNF PLCE CAR W REV POST MAT BABA HAS T ATHM POSHZ BITA TSLA VZ AAOI STRP DPZ HTZ TUES PZZA
For the past several years, streaming giant Netflix (NASDAQ:NFLX) and pizza giant Domino’s (NYSE:DPZ) have rallied side by side as the at-home economy has grown in popularity. Put simply, consumers are staying home more often than they used to. That means more binge-watching Netflix shows and more binge-eating Domino’s pizzas, which are conveniently delivered.
GRUB NFLX JACK DPZ MCD
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549
2018-08-13 - Asif
Core Business At Ballard, Ballard Power Systems is building a clean energy growth company. Ballard Power Systems is recognized as a world leader in proton exchange membrane (“PEM”) fuel cell power system development and commercialization. The company's principal business is the design, development, manufacture, sale and service of PEM fuel cell products for a variety of applications, focusing on its power product markets of Heavy-Duty Motive (consisting of bus, truck, rail and marine applications), Portable Power, Material Handling and Backup Power, as well as the delivery of Technology Solutions, including engineering services, technology transfer, and the license and sale of its extensive intellectual property portfolio and fundamental knowledge for a variety of fuel cell applications. A fuel cell is an environmentally clean electrochemical device that combines hydrogen fuel with oxygen (from the air) to produce electricity. The hydrogen fuel can be obtained from natural g...
2018-08-13 - Asif
Overview Marathon Patent Group was incorporated in the State of Nevada on February 23, 2010 under the name Verve Ventures, Inc. On December 7, 2011, the company changed its name to American Strategic Minerals Corporation and were engaged in exploration and potential development of uranium and vanadium minerals business. In June 2012, the company discontinued its minerals business and began to invest in real estate properties in Southern California. In October 2012, the company discontinued its real estate business when its former CEO joined the firm and the company commenced its IP licensing operations, at which time the Company’s name was changed to Marathon Patent Group, Inc. On November 1, 2017, the company entered into a merger agreement with Global Bit Ventures, Inc. (“GBV”), which is focused on mining digital assets. Marathon Patent Group has since purchased its cryptocurrency mining machines and established a data center in Canada to mine digital assets. Following the me...
2018-08-13 - Asif
Business and Organization Endocyte, Inc. is a biopharmaceutical company and leader in developing targeted therapies for the treatment of cancer. The Company uses drug conjugation technology to create novel therapeutics and companion imaging agents for personalized targeted therapies. The agents actively target receptors that are over-expressed on diseased cells relative to healthy cells, such as prostate specific membrane antigen (“PSMA”) in prostate cancer. This targeted approach is designed to safely enable the delivery of highly potent drug payloads. The companion imaging agents are designed to identify patients whose disease over-expresses the target of the therapy and who are therefore more likely to benefit from treatment. In September 2017, the Company entered into a Development and License Agreement (the “License Agreement”) with ABX advanced biochemical compounds – Biomedizinische Forschungsreagenzien GmbH (“ABX”), pursuant to which the Company acquired exclusive ...
as of ET